Cytosorbents Corp - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS

Ticker Exchange SIC # Website Latest Ticker
CTSO Nasdaq 3845 https://cytosorbents.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cytosorbents Corp

CTSO: CytoSorbents reports 3rd quarter 2023 financial and operating results which showed strong product revenue growth and an improved cost structure. - Nov 14th, 2023 1:10 pm
Q3 2023 Cytosorbents Corp Earnings Call - Nov 10th, 2023 2:42 pm
Cytosorbents Corporation (NASDAQ:CTSO) Q3 2023 Earnings Call Transcript - Nov 10th, 2023 1:52 pm
CytoSorbents Reports Third Quarter 2023 Financial and Operational Results - Nov 9th, 2023 9:15 pm
CytoSorbents to Report Third Quarter 2023 Operating and Financial Results - Oct 27th, 2023 11:00 am
CytoSorbents to Present at the 8th Annual Dawson James Conference - Oct 5th, 2023 11:00 am
CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry - Sep 27th, 2023 11:00 am
Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference - Sep 21st, 2023 1:35 pm
CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer - Sep 19th, 2023 11:00 am
CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantation - Sep 11th, 2023 3:32 pm
CytoSorbents Announces Resignation of Chief Financial Officer Alexander D’Amico - Sep 1st, 2023 8:43 pm
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil - Aug 31st, 2023 11:00 am
Cytosorbents (NASDAQ:CTSO) shareholders have endured a 83% loss from investing in the stock five years ago - Aug 27th, 2023 1:52 pm
CytoSorbents Completes U.S. and Canadian STAR-T Pivotal Trial - Aug 14th, 2023 11:00 am
CTSO: CytoSorbents reports 2nd quarter 2023 financial and results which showed strong product revenue growth and an improved cost structure. - Aug 3rd, 2023 1:10 pm
Q2 2023 Cytosorbents Corp Earnings Call - Aug 2nd, 2023 1:02 pm
CytoSorbents Reports Second Quarter 2023 Financial and Operational Results - Aug 1st, 2023 8:15 pm
Several Insiders Invested In Cytosorbents Flagging Positive News - Jul 31st, 2023 11:31 am
CytoSorbents to Report Second Quarter 2023 Operating and Financial Results - Jul 26th, 2023 11:00 am
CytoSorbents Appoints Alexander D’Amico as Chief Financial Officer - Jul 19th, 2023 11:00 am